The third world textiles conference ‘Smartex-2013’ will take place from 14th to 16th May, 2013, at Sharm Elsheakh, Egypt. The forthcoming event will bring several textile experts together from various manufacturing companies, ...
Tags: world textiles conference, textile materials, textile market
The third world textiles conference ‘Smartex-2013’ will take place from 14th to 16th May, 2013, at Sharm Elsheakh, Egypt. The forthcoming event will bring several textile experts together from various manufacturing companies, ...
Tags: world textiles conference, textile materials, textile market
Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have entered into a partnership to develop a systemically delivered RNAi therapeutic, ALN-VSP, for the treatment of liver cancers including hepatocellular carcinoma (HCC). Under the ...
Tags: Alnylam Pharmaceuticals, Ascletis Pharmaceuticals, HCC, ALN-VSP
ARLINGTON, Va. - November 2, 2012 - The American Composites Manufacturers Association (ACMA) and Society for the Advancement of Material and Process Engineering (SAMPE) Boards of Directors are excited and pleased to announce the signing of ...
Tags: Material and Process Engineering, composites industry, ACMA
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Mr Alexey Miller chairman of the Gazprom Management Committee took part in commissioning of the upgraded Zapadnaya gas distribution station in Minsk. The event was also attended by Mr Vladimir Semashko first deputy Prime Minister of ...
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Tags: lect drug candidates, antiviral drugs, viral infections
Novavax has reported a net loss of $7.22m, or $0.05 per share, for the third quarter ended 30 September 2012 compared to a net loss of $3.21m, or $0.03 per share, for the third quarter ended 30 September 2011. Revenue for third quarter of ...
Tags: Novavax, Wider Q3 Net Loss, net loss, clinical trials
Advanced Cancer Therapeutics (ACT) has received Phase I small business innovative research (SBIR) grant of $158,000 from the National Cancer Institute of the National Institutes of Health (NIH) to support the development of an anti cancer ...
Tags: ACT, SBIR Grant, anti cancer drug, Anticancer Drug
Lighting Science Group Corporation (OTCBB: LSCG), one of the world's leading LED lighting technology companies, announced today that its DEFINITY™ MR16 high-output LED lamp and the DEFINITY™ BR20 LED lamp has been recognized by ...
Tags: LEDs Lighting, LED replacement lamps, LSCG
Cooper Lighting, a leader at the forefront of transforming the lighting industry and setting an unmatched standard for innovation and reliability, announces that 14 of its innovative and reliable products – include 13 LED luminaires ...
Tags: LED high output square downlight, Cooper Lighting, lighting industry
Baxter International has collaborated with Chatham Therapeutics for the development and commercialization of factor IX hemophilia B gene therapy treatment. According to the agreement, the companies will investigate the next generation of ...
Tags: IX hemophilia B gene therapy, Biological Nano Particles, clinical trials
Merck and Ablynx have entered into a partnership to develop Nanobody candidates against a voltage gated ion channel and includes an option to elect a second target. As a part of the agreement, Ablynx will be responsible for the discovery ...
Tags: Nanobody Candidates, Nanobody technology, Ablynx Partner
November 20, 2012 - Toronto’s Ryerson University launched what it calls Canada’s first business incubator and accelerator devoted solely to urban energy. Housed at the Centre for Urban Energy (CUE), the Innovation Centre for ...
Tags: business incubator, urban energy, new energy
Volcano, a manufacturer of precision guided therapy tools, has entered into a definitive agreement to buy Israel-based Sync-Rx. Sync-Rx is involved in developing advanced software technologies to facilitate transcatheter cardiovascular ...
Tags: Volcano, precision guided therapy tools, Israel-based Sync-Rx